+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Mar 2023 | From USD $2900 | Published By: MARKET INTELLIGENCE DATA | Number Of Pages: 112
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
According to our (Global Info Research) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at USD 1424.5 million in 2022 and is forecast to a readjusted size of USD 9195.8 million by 2029 with a CAGR of 30.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report is a detailed and comprehensive analysis for global CRISPR and CRISPR-Associated (Cas) Genes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global CRISPR and CRISPR-Associated (Cas) Genes market size and forecasts, in consumption value ($ Million), 2018-2029
Global CRISPR and CRISPR-Associated (Cas) Genes market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global CRISPR and CRISPR-Associated (Cas) Genes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global CRISPR and CRISPR-Associated (Cas) Genes market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRISPR and CRISPR-Associated (Cas) Genes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRISPR and CRISPR-Associated (Cas) Genes market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
CRISPR and CRISPR-Associated (Cas) Genes market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Market segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Market segment by players, this report covers
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRISPR and CRISPR-Associated (Cas) Genes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR and CRISPR-Associated (Cas) Genes, with revenue, gross margin and global market share of CRISPR and CRISPR-Associated (Cas) Genes from 2018 to 2023.
Chapter 3, the CRISPR and CRISPR-Associated (Cas) Genes competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CRISPR and CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR and CRISPR-Associated (Cas) Genes.
Chapter 13, to describe CRISPR and CRISPR-Associated (Cas) Genes research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of CRISPR and CRISPR-Associated (Cas) Genes
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CRISPR and CRISPR-Associated (Cas) Genes by Type
1.3.1 Overview: Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type in 2022
1.3.3 Genome Editing
1.3.4 Genetic engineering
1.3.5 gRNA Database/Gene Librar
1.3.6 CRISPR Plasmid
1.3.7 Human Stem Cells
1.3.8 Genetically Modified Organisms/Crops
1.3.9 Cell Line Engineering
1.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market by Application
1.4.1 Overview: Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Biotechnology Companies
1.4.3 Pharmaceutical Companies
1.4.4 Academic Institutes
1.4.5 Research and Development Institutes
1.5 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size & Forecast
1.6 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast by Region
1.6.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region, (2018-2029)
1.6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2018-2029)
1.6.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2018-2029)
1.6.6 South America CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Editas Medicine
2.2.1 Editas Medicine Details
2.2.2 Editas Medicine Major Business
2.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Editas Medicine Recent Developments and Future Plans
2.3 Caribou Biosciences
2.3.1 Caribou Biosciences Details
2.3.2 Caribou Biosciences Major Business
2.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Caribou Biosciences Recent Developments and Future Plans
2.4 CRISPR therapeutics
2.4.1 CRISPR therapeutics Details
2.4.2 CRISPR therapeutics Major Business
2.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CRISPR therapeutics Recent Developments and Future Plans
2.5 Intellia therapeutics, Inc.
2.5.1 Intellia therapeutics, Inc. Details
2.5.2 Intellia therapeutics, Inc. Major Business
2.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Intellia therapeutics, Inc. Recent Developments and Future Plans
2.6 Cellectis
2.6.1 Cellectis Details
2.6.2 Cellectis Major Business
2.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cellectis Recent Developments and Future Plans
2.7 Horizon Discovery Plc
2.7.1 Horizon Discovery Plc Details
2.7.2 Horizon Discovery Plc Major Business
2.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Horizon Discovery Plc Recent Developments and Future Plans
2.8 Sigma Aldrich
2.8.1 Sigma Aldrich Details
2.8.2 Sigma Aldrich Major Business
2.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sigma Aldrich Recent Developments and Future Plans
2.9 Precision Biosciences
2.9.1 Precision Biosciences Details
2.9.2 Precision Biosciences Major Business
2.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Precision Biosciences Recent Developments and Future Plans
2.10 Genscript
2.10.1 Genscript Details
2.10.2 Genscript Major Business
2.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Genscript Recent Developments and Future Plans
2.11 Sangamo Biosciences Inc.
2.11.1 Sangamo Biosciences Inc. Details
2.11.2 Sangamo Biosciences Inc. Major Business
2.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sangamo Biosciences Inc. Recent Developments and Future Plans
2.12 Lonza Group Limited
2.12.1 Lonza Group Limited Details
2.12.2 Lonza Group Limited Major Business
2.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lonza Group Limited Recent Developments and Future Plans
2.13 Integrated DNA Technologies
2.13.1 Integrated DNA Technologies Details
2.13.2 Integrated DNA Technologies Major Business
2.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Integrated DNA Technologies Recent Developments and Future Plans
2.14 New England Biolabs
2.14.1 New England Biolabs Details
2.14.2 New England Biolabs Major Business
2.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 New England Biolabs Recent Developments and Future Plans
2.15 Origene Technologies
2.15.1 Origene Technologies Details
2.15.2 Origene Technologies Major Business
2.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
2.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Origene Technologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company Revenue
3.2.2 Top 3 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share in 2022
3.2.3 Top 6 CRISPR and CRISPR-Associated (Cas) Genes Players Market Share in 2022
3.3 CRISPR and CRISPR-Associated (Cas) Genes Market: Overall Company Footprint Analysis
3.3.1 CRISPR and CRISPR-Associated (Cas) Genes Market: Region Footprint
3.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Type Footprint
3.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value and Market Share by Type (2018-2023)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application (2018-2023)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast by Application (2024-2029)
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2029)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2029)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
6.3.1 North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2029)
6.3.2 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
6.3.3 Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
6.3.4 Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2029)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2029)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2029)
7.3.2 Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
7.3.3 France CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
7.3.4 United Kingdom CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
7.3.5 Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
7.3.6 Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2029)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2029)
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region
8.3.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2018-2029)
8.3.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
8.3.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
8.3.4 South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
8.3.5 India CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
8.3.7 Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
9 South America
9.1 South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2029)
9.2 South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2029)
9.3 South America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
9.3.1 South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2029)
9.3.2 Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
9.3.3 Argentina CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2029)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2029)
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country
10.3.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2029)
10.3.2 Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
10.3.4 UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
11.2 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
11.3 CRISPR and CRISPR-Associated (Cas) Genes Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Chain
12.2 CRISPR and CRISPR-Associated (Cas) Genes Upstream Analysis
12.3 CRISPR and CRISPR-Associated (Cas) Genes Midstream Analysis
12.4 CRISPR and CRISPR-Associated (Cas) Genes Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Scientific Major Business
Table 7. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 8. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Scientific Recent Developments and Future Plans
Table 10. Editas Medicine Company Information, Head Office, and Major Competitors
Table 11. Editas Medicine Major Business
Table 12. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 13. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Editas Medicine Recent Developments and Future Plans
Table 15. Caribou Biosciences Company Information, Head Office, and Major Competitors
Table 16. Caribou Biosciences Major Business
Table 17. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 18. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Caribou Biosciences Recent Developments and Future Plans
Table 20. CRISPR therapeutics Company Information, Head Office, and Major Competitors
Table 21. CRISPR therapeutics Major Business
Table 22. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 23. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. CRISPR therapeutics Recent Developments and Future Plans
Table 25. Intellia therapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 26. Intellia therapeutics, Inc. Major Business
Table 27. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 28. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Intellia therapeutics, Inc. Recent Developments and Future Plans
Table 30. Cellectis Company Information, Head Office, and Major Competitors
Table 31. Cellectis Major Business
Table 32. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 33. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Cellectis Recent Developments and Future Plans
Table 35. Horizon Discovery Plc Company Information, Head Office, and Major Competitors
Table 36. Horizon Discovery Plc Major Business
Table 37. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 38. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Horizon Discovery Plc Recent Developments and Future Plans
Table 40. Sigma Aldrich Company Information, Head Office, and Major Competitors
Table 41. Sigma Aldrich Major Business
Table 42. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 43. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sigma Aldrich Recent Developments and Future Plans
Table 45. Precision Biosciences Company Information, Head Office, and Major Competitors
Table 46. Precision Biosciences Major Business
Table 47. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 48. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Precision Biosciences Recent Developments and Future Plans
Table 50. Genscript Company Information, Head Office, and Major Competitors
Table 51. Genscript Major Business
Table 52. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 53. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Genscript Recent Developments and Future Plans
Table 55. Sangamo Biosciences Inc. Company Information, Head Office, and Major Competitors
Table 56. Sangamo Biosciences Inc. Major Business
Table 57. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 58. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Sangamo Biosciences Inc. Recent Developments and Future Plans
Table 60. Lonza Group Limited Company Information, Head Office, and Major Competitors
Table 61. Lonza Group Limited Major Business
Table 62. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 63. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Lonza Group Limited Recent Developments and Future Plans
Table 65. Integrated DNA Technologies Company Information, Head Office, and Major Competitors
Table 66. Integrated DNA Technologies Major Business
Table 67. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 68. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Integrated DNA Technologies Recent Developments and Future Plans
Table 70. New England Biolabs Company Information, Head Office, and Major Competitors
Table 71. New England Biolabs Major Business
Table 72. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 73. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. New England Biolabs Recent Developments and Future Plans
Table 75. Origene Technologies Company Information, Head Office, and Major Competitors
Table 76. Origene Technologies Major Business
Table 77. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Solutions
Table 78. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Origene Technologies Recent Developments and Future Plans
Table 80. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (USD Million) by Players (2018-2023)
Table 81. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players (2018-2023)
Table 82. Breakdown of CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in CRISPR and CRISPR-Associated (Cas) Genes, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key CRISPR and CRISPR-Associated (Cas) Genes Players
Table 85. CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Type Footprint
Table 86. CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Application Footprint
Table 87. CRISPR and CRISPR-Associated (Cas) Genes New Market Entrants and Barriers to Market Entry
Table 88. CRISPR and CRISPR-Associated (Cas) Genes Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Share by Type (2018-2023)
Table 91. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Forecast by Type (2024-2029)
Table 92. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2023)
Table 93. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Forecast by Application (2024-2029)
Table 94. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Country (2024-2029) & (USD Million)
Table 124. CRISPR and CRISPR-Associated (Cas) Genes Raw Material
Table 125. Key Suppliers of CRISPR and CRISPR-Associated (Cas) Genes Raw Materials
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type in 2022
Figure 4. Genome Editing
Figure 5. Genetic engineering
Figure 6. gRNA Database/Gene Librar
Figure 7. CRISPR Plasmid
Figure 8. Human Stem Cells
Figure 9. Genetically Modified Organisms/Crops
Figure 10. Cell Line Engineering
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 12. CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application in 2022
Figure 13. Biotechnology Companies Picture
Figure 14. Pharmaceutical Companies Picture
Figure 15. Academic Institutes Picture
Figure 16. Research and Development Institutes Picture
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 19. Global Market CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Region (2018-2029)
Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Region in 2022
Figure 22. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 25. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 27. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players in 2022
Figure 28. CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 29. Global Top 3 Players CRISPR and CRISPR-Associated (Cas) Genes Market Share in 2022
Figure 30. Global Top 6 Players CRISPR and CRISPR-Associated (Cas) Genes Market Share in 2022
Figure 31. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Share by Type (2018-2023)
Figure 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2024-2029)
Figure 33. Global CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Share by Application (2018-2023)
Figure 34. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2024-2029)
Figure 35. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type (2018-2029)
Figure 36. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application (2018-2029)
Figure 37. North America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Country (2018-2029)
Figure 38. United States CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 39. Canada CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 40. Mexico CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type (2018-2029)
Figure 42. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application (2018-2029)
Figure 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 45. France CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 46. United Kingdom CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 47. Russia CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 48. Italy CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 49. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type (2018-2029)
Figure 50. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application (2018-2029)
Figure 51. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Region (2018-2029)
Figure 52. China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 53. Japan CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 54. South Korea CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 55. India CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 56. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 57. Australia CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 58. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type (2018-2029)
Figure 59. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application (2018-2029)
Figure 60. South America CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Country (2018-2029)
Figure 61. Brazil CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 62. Argentina CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 63. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Type (2018-2029)
Figure 64. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Application (2018-2029)
Figure 65. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Country (2018-2029)
Figure 66. Turkey CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 67. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 68. UAE CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2018-2029) & (USD Million)
Figure 69. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Figure 70. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Figure 71. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of CRISPR and CRISPR-Associated (Cas) Genes in 2022
Figure 74. Manufacturing Process Analysis of CRISPR and CRISPR-Associated (Cas) Genes
Figure 75. CRISPR and CRISPR-Associated (Cas) Genes Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
